Five things for pharma marketers to know: Wednesday, February 28, 2018

FDA declines to review potential Celgene MS blockbuster; AstraZeneca to spin off autoimmune drug unit; Justice Department to back prescription opioid lawsuit.

from Most popular articles from Medical Marketing and Media http://ift.tt/2GPpABI